Researchers from University of California San Diego have identified changes in the metabolic activity of the gut microbiome associated with exceptional longevity in humans and found that amplifying the same activity with engineered bacteria improved metabolic health in aged mice. The study, published on Nov. 16, 2026 in the journal Cell Metabolism, suggests that some changes in the gut microbiome that occur with aging may be protective adaptations rather than signs of decline - and could potentially be harnessed to support healthier aging.
Many studies of aging focus on what goes wrong as we get older, but our findings suggest that some changes in the gut microbiome may actually represent the body's attempt to preserve metabolic health. If we can identify those beneficial functions and safely strengthen them, we may eventually be able to develop new ways to promote healthier aging."
Amir Zarrinpar, MD, PhD, senior author, Stuart and Barbara L. Brody Endowed Chair in Circadian Biology and Medicine, and professor of medicine, UC San Diego School of Medicine
The gut microbiome - the community of bacteria and other microbes living in the digestive tract - changes throughout life and plays an important role in metabolism, inflammation and other aspects of health. Previous research has linked age-related changes in the microbiome with frailty, chronic inflammation and disease, while other studies have found distinctive microbiome features among people who age exceptionally well.
In the new study, researchers focused on how gut microbes modify bile acids, substances produced by the liver that help digest fats but also act as signaling molecules throughout the body. Gut bacteria produce enzymes called bile salt hydrolases (BSH) that chemically modify bile acids, allowing them to influence pathways involved in metabolism, inflammation and the body's internal clock.
The researchers first studied young and aged mice and found that aging was associated with increased microbial activity related to BSH and greater bile acid modification. To determine whether a similar pattern occurred in humans, they reanalyzed publicly available data from a human aging cohort. The analysis included bile acid measurements from 48 young adults, 107 older adults and 125 centenarians. The centenarian group showed higher ratios of certain modified bile acids than both younger groups. Analysis of microbiome data also found greater abundance of a gene associated with BSH activity among centenarians compared with the older adult group.
The researchers then asked whether enhancing this microbial function could produce health benefits. They engineered a strain of bacteria native to the gut to continuously produce BSH and introduced it into 82-week-old mice - considered aged. A single treatment resulted in stable colonization, allowing the bacteria to persist and produce the enzyme over time.
Approximately 20 weeks after treatment, mice receiving the BSH-producing bacteria had significantly improved insulin sensitivity and modestly improved glucose tolerance compared with mice receiving a matched control bacterium. By 32 weeks, the treated mice also showed changes consistent with lower body weight and fat mass and greater lean mass. Other findings pointed to increased use of fat for energy, improved mitochondrial function and changes in gene activity related to inflammation and the body's internal clock.
The results do not show that the microbial changes caused exceptional longevity in humans or that the engineered bacteria can extend lifespan. The authors note that centenarians and aged mice are not directly comparable, and the human findings provide supporting rather than definitive evidence. More studies in people will be needed to determine whether increased BSH activity is a marker of healthy aging, a contributor to it, or both.
The study also points toward a broader possibility: rather than attempting to replace the entire gut microbiome, researchers may eventually be able to identify beneficial microbial functions and selectively enhance them. Future studies will investigate how different forms of BSH affect bile acid metabolism, inflammation, energy use and other aspects of aging, as well as whether the approach works similarly in females, given established differences in aging based on sex.
"The goal isn't simply to live longer - it's to understand the biology that allows some people to remain resilient as they age," said Zarrinpar. "The microbiome gives us an intriguing opportunity because, unlike many aspects of aging, it may be something we can modify. This study gives us a starting point for asking whether beneficial microbial functions can be amplified to help preserve metabolic health later in life."
Source:
Journal reference:
Dantas Machado, A. C., et al. (2026). Microbial bile acid deconjugation counters metabolic decline in aging. Cell Metabolism. DOI: 10.1016/j.cmet.2026.10.016. https://www.cell.com/cell-metabolism/abstract/S1550-4131(26)00453-5